Modifying acute otitis media: implications of immunization with pneumococcal conjugate vaccine.
Pelton
Stephen I
SI
Department of Pediatrics, Boston Medical Center, Boston, MA, USA.
D000208:Acute Disease; D017677:Age Distribution; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007115:Immunization Schedule; D015994:Incidence; D007223:Infant; D008297:Male; D022401:Meningococcal Vaccines / Q000008:administration & dosage*; D010033:Otitis Media / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D011008:Pneumococcal Infections / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011379:Prognosis; D018570:Risk Assessment; D017678:Sex Distribution; D013296:Streptococcus pneumoniae / Q000276:immunology; D014611:Vaccination
D000900:Anti-Bacterial Agents; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022401:Meningococcal Vaccines; D022242:Pneumococcal Vaccines